JUN and anthrax infection: However, the cAMP assay was validated using a self-developed human-anti-PA monoclonal antibody [37] and the TNA was validated using human anti-anthrax vaccine adsorbed (AVA) [38]; therefore, a side-by-side study using the same testing material would be necessary to definitively compare AP-1 reporter, TNA, and cAMP assay performance.